Nanocarriers and Drug Delivery Systems

• 3010 · PDF LIN-T (lipid integrated tag): An optimized tag-lipid nanoparticle design for targeted therapeutic mRNA delivery Tommy Lidström, Alexandros Kostakis, Rosanne Veerman, Venera Emruli, Safia Guleed, Tina Furebring, Jonas A. Nilsson, Sara Mangsbo
• 3011 · PDF A STING-boosted lipid nanoparticle mRNA vaccine for therapeutic cancer vaccination Alessia Marrocu, Osama W. M. Hassuneh, Victor M. Moreno Zafra, Alaa Zam, Emre Demirel, Meriem Bahri, Adam Walters, James N. Arnold, Khuloud T. Al-Jamal
• 3012 · PDF Lipid nanoparticles enable high efficiency CRISPR HDR mediated gene insertions in primary human T cells Reka Geczy, Meenakshi Swaminathan, Hannah Ly, Mana Novin, Bernice Thommandru, Sijo Chemmannur, Sadik Kassim, Samuel Clarke
• 3013 3013 Biomimetic exosome-delivered STAT3 inhibitor for radiosensitization in oral squamous cell carcinoma cells Kehua Hu, Sisi Yan, Xiaowan Guo, Rurui Xue, Yunli Mo, Hui Qiu, Linlin Bu, Qiuji Wu
• 3014 3014 Targeting PLXND1 using RNA bioengineering technologies and customized lipid nanoparticles in advanced prostate cancer Huan Qu, Menghuan Tang, Qiufang Zong, Sohaib Mahri, Pengfei Xu, Joy C. Yang, Fan Wei, Junwei Zhao, Meijuan Tu, Neelu Bartra, Leyi Wang, Allen C. Gao, Kit Lam, Marc A. Dall'Era, Aiming Yu, Yuanpei Li, Chengfei Liu
• 3015 · PDF Advancing mRNA therapeutics towards immuno-oncology applications: Lipid nanoparticles demonstrate favorable safety and efficacy profile with repeated mRNA administration in normal and tumor-bearing mice Sams MA Sadat, Avisek Deyati, Leanna Yee, Zhengyu Chen, Kalyan Golla, Tony Wu, Richard Jiang, Jay Paquette, Malathi Anantha, Noorjahan Aibani, Nikita Jain, Anitha Thomas
• 3016 · PDF Enhancing CX-5461 therapy in TNBC through liposomal delivery and ATR inhibitor combination Henos S. Negash, Rachel K. Myrick, Sandro R.P. da Rocha, J. Chuck Harrell
• 3017 · PDF Combination effect of vinorelbine and doxorubicin in free solutions and liposomes in a multicellular spheroids model Yong Zhu, Zizhao Xu, Yifan Lu, Shen Zhao, Md Delowar Hossain, Xin Guo
• 3018 · PDF Lipopolymer-mediated delivery of fusion oncogene-targeting siRNAs attenuates leukemia burden and improves survival in preclinical models of hematologic malignancies Mohammad Nasrullah, Remant KC, Spencer B. Gibson, Xiaoyan Jiang, Olaf Heidenreich, Joseph Brandwein, Hasan Uludag
• 3019 · PDF The first coacervate based delivery system for efficient and safe genetic engineering in stem cells Peipei Zhu, Manman Lu, Qing Zhang, Renxia Zhang, Lihong Jiang, Xiaowen Fei, Xiaofei Gao
• 3020 · PDF Lymphocyte-mimetic drug carriers enable targeted therapeutic delivery to lymph nodes for enhanced immunomodulation Michael J. Donzanti, Luisa A. Fink, Bahar Bahramimeimandi, Kayla Katz, Dylan T. Ngo, Ana Obradovic, Ryan Zurakowski, Jason P. Gleghorn
• 3021 · PDF ONM-421, a pH-responsive polymer-drug conjugate nanoparticle, delivers MMAE to solid tumors and shows antigen-independent antitumor efficacy in mice Jason B. Miller, Stephen Gutowski, Qingtai Su, Bhargavi Allu, Austin Burcham, Zirong Chen, Ruolan Han, Tian Zhao
• 3022 · PDF A peptide-based drug delivery system to target metastatic prostate cancer Yukihito Kuroda, Norio Miyamura, Chisato M. Yamazaki, Erkki Ruoslahti, Tambet Teesalu, Kazuki Sugahara
• 3023 · PDF Capsaicin nanoparticles display robust growth-inhibitory activity in human NSCLC Kushal Jignesh Modi, Reagan S. Light, Kaitlyn B. Conley, Sarah L. Miles, Piyali Dasgupta
• 3024 · PDF Enhancing targeted delivery in multiple myeloma via novel NCI-H929 lipid-extracted-modified nanoliposomes Kenny D. Pham, Shivmani Barve, Robert B. Campbell
• 3025 · PDF Self-synergizing mutual prodrug liposomes co-targeting redox homeostasis and PIN1 for cancer therapy Nuri Kim, Dongwon Lee
• 3026 · PDF A polymer-drug conjugate platform for tumor specific drug delivery: Advancement of a clinically validated ultra pH-sensitive micelle technology Qingtai Su, Stephen Gutowski, Bhargavi Allu, Austin Burcham, Zirong Chen, Ruolan Han, Jason B. Miller, Tian Zhao
• 3027 · PDF Cellular uptake of nanoliposomes with optimized cholesterol concentration and lipid extract derived from a model low grade serous ovarian carcinoma cell line Sofia Orlando, Krishna Panchal, Heer Patel, Robert B. Campbell
• 3028 · PDF Investigating phosphatidylcholine and phosphoethanolamine phospholipids in conventional and novel cationic nanoliposomes for interactions with chronic myeloid leukemia cells in vitro Shivmani Y. Barve, Robert B. Campbell
• 3029 · PDF A modular lipid-based oral drug delivery system for precision combination chemotherapy in breast cancer Shailvi Soni, Terrick Andey
• 3030 · PDF SU-CCS-1 lipid extract-modified nanoliposomes and characteristic growth profile of a model clear cell sarcoma target cell line Ashley Silva, Abigail Chan, Simoun Banoud, Charloote Bouchard, Robert B. Campbell
• 3031 · PDF Enhanced delivery of doxorubicin via milk-derived extracellular vesicles in lung cancer cells Cayden Xuanzhang Xia, Elise Copeland, Akhil Srivastava
• 3032 · PDF Electroporation-enhanced targeted bleomycin delivery for the treatment of canine perianal tumors Sergio Fernando Salgado, Josmell David Mestanza, Andrea Hatsumi Bazan, Micaela Vizquerra, Mitzi Westreicher, Nandi Ken Candela
• 3033 · PDF Electrochemotherapy for rectal adenocarcinoma: Advancing drug delivery through electroporation Sergio Fernando Salgado, Josmell David Mestanza, Micaela Vizquerra, Mitzi Westreicher, Nandi Ken Candela, Andrea Hatsumi Bazan
• 3034 · PDF Feasibility and safety of electroporation-enhanced bleomycin delivery for the treatment of parenchymal tumors in dogs and cats Sergio Fernando Salgado, Andrea Hatsumi Bazan, Josmell David Mestanza, Nandi Ken Candela, Mitzi Westreicher, Micaela Vizquerra
• 3035 · PDF Electrochemotherapy as an innovative drug delivery modality for local control of canine acanthomatous ameloblastoma Sergio Fernando Salgado, Andrea Hatsumi Bazan, Josmell David Mestanza, Micaela Vizquerra, Nandi Ken Candela, Mitzi Westreicher
• 3036 · PDF Intellipulse platform for efficient and effective delivery of therapeutics to solid tumors Richard Heller, Loree Heller, Jody Synowiec, Julie Singh, Alex Otten, Mark J. Jaroszeski
• 3037 · PDF Investigating the therapeutic potential of a nanocrystal PRMT5 inhibitor in pancreatic ductal adenocarcinoma Faranak Alipourgivi, Zhongyue (Claire) Yuan, Rahaf Habboub, Yoon Yeo, Tao Lu

在会议检索中浏览本分会场